Home Articles List Article Information
Iranian Journal of Pharmaceutical Research
Journal Archive
Volume Volume 18 (2019)
Volume Volume 17 (2018)
Volume Volume 16 (2017)
Volume Volume 15 (2016)
Volume Volume 14 (2015)
Volume Volume 13 (2014)
Volume Volume 12 (2013)
Volume Volume 11 (2012)
Volume Volume 10 (2011)
Volume Volume 9 (2010)
Volume Volume 8 (2009)
Volume Volume 7 (2008)
Volume Volume 6 (2007)
Volume Volume 5 (2006)
Volume Volume 4 (2005)
Volume Volume 3 (2004)
Volume Volume 2 (2003)
Volume Volume 1 (2002)
Abolfazli, S., Mohammadzadeh, M., Peiravian, F., Zonoozi, J., Sharifnia, H., Vashegani, A. (2019). Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry. Iranian Journal of Pharmaceutical Research, 18(1), 531-545. doi: 10.22037/ijpr.2019.2353
Seyyed Abolfazl Abolfazli; Mehdi Mohammadzadeh; Farzad Peiravian; Jafar Zonoozi; Hesam Sharifnia; Ali Vashegani. "Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry". Iranian Journal of Pharmaceutical Research, 18, 1, 2019, 531-545. doi: 10.22037/ijpr.2019.2353
Abolfazli, S., Mohammadzadeh, M., Peiravian, F., Zonoozi, J., Sharifnia, H., Vashegani, A. (2019). 'Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry', Iranian Journal of Pharmaceutical Research, 18(1), pp. 531-545. doi: 10.22037/ijpr.2019.2353
Abolfazli, S., Mohammadzadeh, M., Peiravian, F., Zonoozi, J., Sharifnia, H., Vashegani, A. Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry. Iranian Journal of Pharmaceutical Research, 2019; 18(1): 531-545. doi: 10.22037/ijpr.2019.2353

Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry

Article 49, Volume 18, Issue 1, Winter 2019, Page 531-545  XML PDF (1018.87 K)
Document Type: Research article
DOI: 10.22037/ijpr.2019.2353
Authors
Seyyed Abolfazl Abolfazli1, 2; Mehdi Mohammadzadeh email 1; Farzad Peiravian1; Jafar Zonoozi3; Hesam Sharifnia1; Ali Vashegani1
1Department of Pharmacoeconomics and Pharmacy Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2Faculty of Economic and Management, Urmia University, Urmia, Iran.
3Department of Business Management, Faculty of Economic and Management, Urmia University, Urmia, Iran.
Abstract
This study investigated the relationship between main dimensions in the strategy-making process, environmental complexity, and performance in pharmaceutical companies of Iran. Results argue that pharmaceutical companies like other industries place differing emphasis on strategy-making and employ different modes of strategy-making. It offers a typology of different modes of strategy-making that most likely exist in pharmaceutical companies and hypothesizes how this typology relates to performance. It then describes the results of an empirical study of the strategy-making processes of pharmaceutical companies. The structural equation analysis of the data from 31 pharmaceutical companies indicates that there are simplistic, adaptive, entrepreneurial, participative, and SPACE (Strategy making Process According to Complexity Environment) modes of strategy-making in pharmaceutical companies; of these modes, SPACE mode exhibited a significant relationship with performance.
Keywords
Strategy-making; Partial least square structural equation modeling; Smart PLS; pharmaceutical companies; SPACE mode
Main Subjects
computional and modelling
Statistics
Article View: 187
PDF Download: 196